Is red meat consumption harmful during Lutetium-177 (LU-177) therapy and hormone therapy for prostate cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Red Meat Consumption During Lutetium-177 and Hormone Therapy for Prostate Cancer

Red meat should be limited during Lutetium-177 (LU-177) therapy and hormone therapy for prostate cancer, with consumption restricted to 1-2 small servings of unprocessed red meat per week, while avoiding processed meats entirely. 1

Rationale for Limiting Red Meat

  • Cancer Risk Association: Several epidemiologic studies have linked high consumption of red meat and processed meats with increased risk of prostate cancer 2. This is particularly concerning for advanced prostate cancer, where higher consumption of processed meat and grilled red meat has been associated with increased risk 3.

  • Cooking Methods Matter: High-temperature cooking methods such as grilling, broiling, or barbecuing produce heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs), which are known carcinogens 3. These compounds may contribute to cancer progression.

  • Hormone Therapy Considerations: When undergoing hormone therapy for prostate cancer, limiting red meat is particularly important as it can contribute to cardiovascular risk factors that may be exacerbated by hormone therapy.

Balanced Approach to Red Meat Consumption

While complete elimination isn't necessary, moderation is key:

  • Quantity: Limit red meat to 1-2 small servings per week 1
  • Quality: Choose unprocessed cuts over processed meats (avoid bacon, sausage, deli meats) 1
  • Preparation: Use cooking methods that minimize formation of carcinogens:
    • Opt for baking, broiling, or poaching rather than frying or charbroiling 2
    • Avoid charring meat or cooking at very high temperatures
    • Use meat as a side dish rather than the main component of meals 2

Alternative Protein Sources

Balance your diet with these healthier protein alternatives:

  • Fish (especially fatty fish rich in omega-3s)
  • Poultry (without skin)
  • Beans and legumes
  • Plant proteins (tofu, tempeh, seitan)
  • Nuts and seeds

Nutritional Support During LU-177 Therapy

LU-177 therapy can cause hematological toxicities including anemia, thrombocytopenia, and leukopenia 1. To support your body during treatment:

  • Iron Sources: While red meat contains highly bioavailable heme iron, you can get iron from other sources like fortified cereals, beans, and dark leafy greens
  • Hydration: Maintain adequate hydration to help your body process and eliminate the radioactive material
  • Antioxidant-Rich Foods: Consume plenty of vegetables and fruits to provide antioxidants and phytonutrients 1
  • Small, Frequent Meals: Consider eating smaller meals more frequently to manage treatment-related side effects 1

Timing Considerations

  • Consume any red meat between treatment cycles rather than immediately before or after LU-177 infusions 1
  • Regular monitoring of blood counts is essential to assess for toxicity and adjust dietary recommendations accordingly 1

Key Takeaways

  1. Limit red meat to 1-2 small servings weekly, focusing on unprocessed cuts
  2. Avoid processed meats entirely
  3. Use cooking methods that minimize carcinogen formation
  4. Emphasize plant-based foods and alternative protein sources
  5. Maintain proper hydration and nutrient intake to support your body during treatment

By following these guidelines, you can help minimize potential risks while maintaining adequate nutrition during your LU-177 and hormone therapy for prostate cancer.

References

Guideline

Nutrition and Management Guidelines for Patients Undergoing Lutetium-177 (LU-177) Infusions for Prostate Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.